PALANTIR BIOCEUTICALS Trademark

Trademark Overview


On Tuesday, May 31, 2022, a trademark application was filed for PALANTIR BIOCEUTICALS with the United States Patent and Trademark Office. The USPTO has given the PALANTIR BIOCEUTICALS trademark a serial number of 97436180. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, July 10, 2023. This trademark is owned by Palantir bioceuticals inc. The PALANTIR BIOCEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Compound meds
palantir bioceuticals

General Information


Serial Number97436180
Word MarkPALANTIR BIOCEUTICALS
Filing DateTuesday, May 31, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, July 10, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCompound meds

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePalantir bioceuticals inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDetroit, MI 48234

Trademark Events


Event DateEvent Description
Monday, July 10, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, July 10, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, July 10, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, March 16, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 16, 2023NON-FINAL ACTION E-MAILED
Thursday, March 16, 2023NON-FINAL ACTION WRITTEN
Thursday, March 16, 2023ASSIGNED TO EXAMINER
Tuesday, June 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 3, 2022NEW APPLICATION ENTERED

Related Keywords


bioceuticals palantir meds compound